Skip to main navigation
Contact Us
EN
Search:
Toggle Navigation
Search:
EN
Main navigation
About Us
Our Company
Management Team
Board of Directors
Clinical Advisory Boards
Contact Us
Pipeline
BLU-5937
Chronic Cough
Chronic Pruritus
Clinical Trials
Science
P2X3 Inhibition
Scientific Publications
Investors & Media
Investors Home
Press Releases
Events & Presentations
Financial Reports & Other
SEC Filings
Other Filings
Stock Information
Stock Quote & Chart
Analyst Coverage
Corporate Governance
Documents & Charters
Management
Board of Directors
Clinical Advisory Boards
Committee Composition
Investor Resources
Investor Contact
FAQs
Email Alerts
Careers
Investors & Media
Event Details
«
Back
BELLUS RELIEF Phase 2 Trial Topline Results
7/6/20 at 8:00 AM EDT
Supporting Materials
Presentation BELLUS RELIEF Phase 2 Trial Topline Results
1.6 MB
